Differences in neuropeptide Y-induced secretion of endothelin-1 in left and right human endocardial endothelial cells

Neuropeptides

Volumn 46, Issue 6, 2012, Pages 373-382

  Abdel Samad, Dima ^a   Perreault, Claudine ^a   Ahmarani, Lena ^a   Avedanian, Levon ^a   Bkaily, Ghassan ^a   Magder, Sheldon ^b   D'Orléans Juste, Pedro ^a   Jacques, Danielle ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Endocardial endothelial cells; Endothelin 1; ET 1 secretion; Excitation secretion coupling; GPCR; Human endothelium; Neuropeptide Y; NPY receptor antagonist; NPY receptors; Y5 receptor

Indexed keywords

ENDOTHELIN 1; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

ARTICLE; CONFOCAL MICROSCOPY; ENDOCARDIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HEART LEFT VENTRICLE MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; STIMULUS SECRETION COUPLING; THREE DIMENSIONAL IMAGING; TIME;

ARGININE; ENDOCARDIUM; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; NEUROPEPTIDE Y; RADIOIMMUNOASSAY; RECEPTORS, NEUROPEPTIDE Y;

EID: 84869861237     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.09.003     Document Type: Article

References (28)

1. Abdel-Samad D., Jacques D., Perreault C., Provost C. NPY regulates human endocardial endothelial cell function. Peptides 2007, 28(2):281-287.
2. Aird W.C. Endothelium as an organ system. Crit. Care Med. 2004, 32(Suppl. 5):S271-S279.
3. Bell D., Allen A.R., Kelso E.J., Balasubramaniam A., McDermott B.J. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. J. Pharmacol. Exp. Ther. 2002, 303(2):581-591.
4. Bkaily G. Single heart cells as models for studying cardiac toxicology. In Vitro Methods in Toxicology 1990, 289-334. Academic Press. G. Jolles, A. Cordier (Eds.).
5. Bkaily G., Pothier P., D'Orleans-Juste P., Simaan M., Jacques D., Jaalouk D., Belzile F., Hassan G., Boutin C., Haddad G., Neugebauer W. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol. Cell. Biochem. 1997, 172(1-2):171-194.
6. Brutsaert D.L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev. 2003, 83(1):59-115.
7. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S., Barnathan E.S., McCrae K.R., Hug B.A., Schmidt A.M., Stern D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91(10):3527-3561.
8. Datta Y.H., Ewenstein B.M. Regulated secretion in endothelial cells: biology and clinical implications. Thromb. Haemost. 2001, 86(5):1148-1155.
9. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol. 1999, 384(2-3):R3-R5.
10. Dumont Y., Cadieux A., Doods H., Fournier A., Quirion R. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). Can. J. Physiol. Pharmacol. 2000, 78(2):116-125.
11. Dumont Y., Cadieux A., Doods H., Pheng L.H., Abounader R., Hamel E., Jacques D., Regoli D., Quirion R. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br. J. Pharmacol. 2000, 129(6):1075-1088.
12. Dumont Y., Jacques D., St-Pierre J.A., Tong Y., Parker R., Herzog H., Quirion R. Neuropeptide Y peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains. Handbook of Neuroanatomy 2000, 375-475. Elsevier Science. R. Quirion, A. Bjorkland, T. Hokfelt (Eds.).
13. Ghersi G., Chen W., Lee E.W., Zukowska Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 2001, 22(3):453-458.
14. Gray G.A., Webb D.J. The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol. Ther. 1996, 72(2):109-148.
15. Jacques D., Descorbeth M., Abdel-Samad D., Provost C., Perreault C., Jules F. The distribution and density of ET-1 and its receptors are different in human right and left ventricular endocardial endothelial cells. Peptides 2005, 26(8):1427-1435.
16. 2+ in human endocardial endothelium. J. Cardiovasc. Pharmacol. 2000, 36(5 Suppl. 1):S397-S400.
17. Jacques D., Sader S., Perreault C., Fournier A., Pelletier G., Beck-Sickinger A.G., Descorbeth M. Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. Can. J. Physiol. Pharmacol. 2003, 81(3):288-300.
18. Kanatani A., Ishihara A., Iwaasa H., Nakamura K., Okamoto O., Hidaka M., Ito J., Fukuroda T., MacNeil D.J., Van der Ploeg L.H., Ishii Y., Okabe T., Fukami T., Ihara M. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist. Biochem. Biophys. Res. Commun. 2000, 272(1):169-173.
19. Kuruvilla L., Kartha C.C. Molecular mechanisms in endothelial regulation of cardiac function. Mol. Cell. Biochem. 2003, 253(1-2):113-123.
20. Loesch A. Perivascular nerves and vascular endothelium: recent advances. Histol. Histopathol. 2002, 17(2):591-597.
21. Pedrazzini T., Pralong F., Grouzmann E. Neuropeptide Y: the universal soldier. Cell. Mol. Life Sci. 2003, 60(2):350-377.
22. Pellieux C., Sauthier T., Domenighetti A., Marsh D.J., Palmiter R.D., Brunner H.R., Pedrazzini T. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc. Natl. Acad. Sci. USA 2000, 97(4):1595-1600.
23. 2+ triggered exocytosis. Science 2002, 298(5594):781-785.
24. Shah A.M., Grocott-Mason R.M., Pepper C.B., Mebazaa A., Henderson A.H., Lewis M.J., Paulus W.J. The cardiac endothelium: cardioactive mediators. Prog. Cardiovasc. Dis. 1996, 39(3):263-284.
25. Uddman R., Moller S., Nilsson T., Nystrom S., Ekstrand J., Edvinsson L. Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues. Peptides 2002, 23(5):927-934.
26. Ullman B., Hulting J., Lundberg J.M. Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Eur. Heart J. 1994, 15(4):454-461.
27. Ullman B., Lindvall K., Lundberg J.M., Sigurdsson A., Swedberg K. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure. Clin. Physiol. 1994, 14(2):123-134.
28. van Mourik J.A., Romani D.W., Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem. Cell Biol. 2002, 117(2):113-122.